Dyne Therapeutics, Inc. DYN Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Dyne Therapeutics, Inc. (DYN) reported comprehensive income (loss), net of tax, attributable to parent of -$121.47M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 5.5% year-over-year, from -$115.13M to -$121.47M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 31.4% compound annual growth rate (CAGR), from -$149.53M to -$445.75M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources during the period, encompassing both net income and other comprehensive income items such as unrealized gains or losses on securities. It provides a comprehensive view of the company's financial performance by including items that bypass the traditional income statement. Investors use this to evaluate the total impact of all financial activities on the company's net worth.